Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
9YV 4-(benzylamino)-6-({4-[(1-methylpiperidin-4-yl)carbamoyl]phenyl}amino)pyridine-3-carboxamide
Non-standard Residues
Code Name Show
PTR O-phosphotyrosine
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 5W86   PDBj   RCSB PDB   PDBe
Header : TRANSFERASE/TRANSFERASE INHIBITOR
Title : CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)
Release Data : 2017-10-11
Compound :
mol_id molecule chains synonym
1 Tyrosine-protein kinase JAK3 A,B,C,D Janus kinase 3,JAK-3,Leukocyte janus kinase,L-JAK
ec: 2.7.10.2
fragment: KINASE DOMAIN (UNP RESIDUES 810-1100)
mutation: YES
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Spodoptera frugiperda  (taxid:7108)
gene: JAK3
expression_system_common: FALL ARMYWORM
expression_system_vector_type: BACULOVIRUS TRANSFER VECTOR
Authors : Sack, J.S.
Keywords : SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
Exp. method : X-RAY DIFFRACTION ( 2.61 Å )
Citation :

Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors.

Bhide, R.S.,Keon, A.,Weigelt, C.  et al.
(2017)  Bioorg. Med. Chem. Lett.  27 : 4908 - 4913

PubMed: 28947151
DOI: 10.1016/j.bmcl.2017.09.029

Chain : A, B, C, D
UniProt : P52333 (JAK3_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl- [protein] 2.7.10.2 PROSITE-ProRule:PRU10028
-